Vol 1 | Issue 3 | October 2018
Make sure you get all the latest updates by subscribing today. Have something to share in the newsletter? Drop us an email at cancercenter@gwu.edu .
The GW Hospital and GW Cancer Center are participating in the Leukemia & Lymphoma Society's "Light the Night Walk" on Saturday, October 20. There's still time to join the team or donate!
Researchers from GW found that nanoparticle-encapsulated doxorubicin is promising in the treatment of triple-negative breast cancer cell lines. The study highlights the benefits of nanomedicine.
Internationally recognized cancer biology researcher Rong Li, PhD, will serve as chair of the Department of Biochemistry and Molecular Medicine at the GW School of Medicine and Health Sciences.
Rachel Brem, MD, program leader of the Breast Cancer Program at the GW Cancer Center, has been instrumental in developing a patient-focused breast imaging program that integrates compassionate care with the latest technology. Check out her Q&A to learn more about what inspires her and why GW is unique when it comes to treating breast cancer.
The latest cancer news
Mark your calendars
Rebecca Lynch, PhD: Evaluating Broadly Neutralizing Antibodies for Targeted ADCC Cure Strategies in the Asia Pacific Region (U.S. Civilian Research and Development Foundation)

Rebecca Kaltman, MD: Cancer Telegenetics for Underserved Women in the D.C. Area: An Innovative Approach to Address Health Disparities (Katzen Pilot Grant)

Erik Rodriguez, PhD: Tools to Image and Treat Cancer (Katzen Pilot Grant)

Avi Dor, PhD: Impact of Policy and System Interventions on HPV Vaccination and Incidence of Cervical Cancer (Katzen Pilot Grant)

Inhee Chung, PhD: Integrated 3D Cellular Imaging Platform for Assessing Cancer Dissemination Potential (Katzen Pilot Grant)